Objectives Proton-pump inhibitors (PPIs) appear to increase the occurrence of cardiovascular occasions in sufferers with coronary artery disease (CAD), mainly in those using clopidogrel. of HF/loss of life [HR = 5.713 (1.628C20.043); p = 0.007], however, not of acute ischaemic…